The survivin -31 snp in human colorectal cancer correlates with survivin splice variant expression and improved overall survival

Cellular Oncology

Volumn 34, Issue 4, 2011, Pages 381-391

  Antonacopoulou, Anna G ^a   Floratou, Konstantina ^a   Bravou, Vasiliki ^a   Kottorou, Anastasia ^a   Dimitrakopoulos, Fotinos Ioannis ^a   Marousi, Stella ^a   Stavropoulos, Michalis ^a   Koutras, Angelos K ^a   Scopa, Chrisoula D ^a   Kalofonos, Haralabos P ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Colorectal cancer; Polymorphism; Splice variant; Survival; Survivin

Indexed keywords

MESSENGER RNA; SURVIVIN; SURVIVIN 2ALPHA; SURVIVIN 2B; SURVIVIN 3B; UNCLASSIFIED DRUG; BIRC5 PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; ALTERNATIVE RNA SPLICING; CELL DIFFERENTIATION; COLORECTAL TUMOR; DISEASE COURSE; EXON; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PROTEIN TRANSPORT; SURVIVAL;

AGED; AGED, 80 AND OVER; ALLELES; ALTERNATIVE SPLICING; CELL DIFFERENTIATION; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; EXONS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBITOR OF APOPTOSIS PROTEINS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN TRANSPORT; SURVIVAL ANALYSIS;

EID: 84865324175     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-011-0038-4     Document Type: Article

References (38)

1. F. Li, Survivin study: What is the next wave? J. Cell. Physiol. 197, 8-29 (2003) (Pubitemid 37486223)
2. F. Li, G. Ambrosini, E.Y. Chu, J. Plescia, S. Tognin, P.C. Marchisio, D.C. Altieri, Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396, 580-584 (1998) (Pubitemid 28563719)
3. G. Ambrosini, C. Adida, D.C. Altieri, A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med. 3, 917-921 (1997) (Pubitemid 27353455)
4. K. Tanaka, S. Iwamoto, G. Gon, T. Nohara, M. Iwamoto, N. Tanigawa, Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin. Cancer Res. 6, 127-134 (2000) (Pubitemid 30064984)
5. M. Monzo, R. Rosell, E. Felip, J. Astudillo, J.J. Sanchez, J. Maestre, C. Martin, A. Font, A. Barnadas, A. Abad, A novel antiapoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. J. Clin. Oncol. 17, 2100-2104 (1999) (Pubitemid 29318841)
6. H. Kawasaki, D.C. Altieri, C.D. Lu, M. Toyoda, T. Tenjo, N. Tanigawa, Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res. 58, 5071-5074 (1998) (Pubitemid 28521163)
7. F. Li, X. Ling, Survivin study: An update of "what is the next wave"? J. Cell. Physiol. 208, 476-486 (2006) (Pubitemid 44141872)
8. C. Mahotka, M. Wenzel, E. Springer, H.E. Gabbert, C.D. Gerharz, Survivin-deltaEx3 and survivin-2B: Two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties. Cancer Res. 59, 6097-6102 (1999) (Pubitemid 30035627)
9. A. Badran, A. Yoshida, K. Ishikawa, T. Goi, A. Yamaguchi, T. Ueda, M. Inuzuka, Identification of a novel splice variant of the human anti-apoptopsis gene survivin. Biochem. Biophys. Res. Commun. 314, 902-907 (2004) (Pubitemid 38112885)
10. S.K. Knauer, C. Bier, P. Schlag, J. Fritzmann, W. Dietmaier, F. Rodel, L. Klein-Hitpass, A.F. Kovacs, C. Doring, M.L. Hansmann, W.K. Hofmann, M. Kunkel, C. Brochhausen, K. Engels, B. M. Lippert, W. Mann, R.H. Stauber, The survivin isoform survivin-3B is cytoprotective and can function as a chromosomal passenger complex protein. Cell Cycle 6, 1502-1509 (2007)
11. H. Caldas, L.E. Honsey, R.A. Altura, Survivin 2alpha: A novel Survivin splice variant expressed in human malignancies. Mol. Cancer 4, 11 (2005)
12. Y. Xu, F. Fang, G. Ludewig, G. Jones, D. Jones, A mutation found in the promoter region of the human survivin gene is correlated to overexpression of survivin in cancer cells. DNA Cell Biol. 23, 527-537 (2004) (Pubitemid 39244331)
13. J.S. Jang, K.M. Kim, K.H. Kang, J.E. Choi, W.K. Lee, C.H. Kim, Y.M. Kang, S. Kam, I.S. Kim, J.E. Jun, T.H. Jung, J.Y. Park, Polymorphisms in the survivin gene and the risk of lung cancer. Lung Cancer 60, 31-39 (2008) (Pubitemid 351434465)
14. A.A. Borbely, M. Murvai, K. Szarka, J. Konya, L. Gergely, Z. Hernadi, G. Veress, Survivin promoter polymorphism and cervical carcinogenesis. J. Clin. Pathol. 60, 303-306 (2007) (Pubitemid 46447748)
15. W.H. Majoros, U. Ohler, Spatial preferences of microRNA targets in 3′ untranslated regions. BMC Genomics 8, 152 (2007)
16. L.M. Veenendaal, O. Kranenburg, N. Smakman, A. Klomp, I.H. Borel Rinkes, P.J. van Diest, Differential Notch and TGFbeta signaling in primary colorectal tumors and their corresponding metastases. Cell. Oncol. 30, 1-11 (2008) (Pubitemid 351161033)
17. W.E. Mesker, G.J. Liefers, J.M. Junggeburt, G.W. van Pelt, P. Alberici, P.J. Kuppen, N.F. Miranda, K.A. van Leeuwen, H. Morreau, K. Szuhai, R.A. Tollenaar, H.J. Tanke, Presence of a high amount of stroma and downregulation of SMAD4 predict for worse survival for stage I-II colon cancer patients. Cell. Oncol. 31, 169-178 (2009)
18. H. Kawasaki, M. Toyoda, H. Shinohara, J. Okuda, I. Watanabe, T. Yamamoto, K. Tanaka, T. Tenjo, N. Tanigawa, Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis. Cancer 91, 2026-2032 (2001) (Pubitemid 32476366)
19. L.F. Fan, W.G. Dong, C.Q. Jiang, Q. Qian, Q.F. Yu, Role of Hypoxia-inducible factor-1 alpha and Survivin in colorectal carcinoma progression. Int. J. Colorectal Dis. 23, 1057-1064 (2008)
20. S. Lassmann, L. Tang, M. Capanu, T. Brabletz, A. Schopflin, A. Zur Hausen, M. Gonen, N. Kemeny, J. Shia, D. Klimstra, M. Werner, Predictive molecular markers for colorectal cancer patients with resected liver metastasis and adjuvant chemotherapy. Gastroenterology 133, 1831-1839 (2007) (Pubitemid 350180803)
21. S. Rozen, H. Skaletsky, Primer3 on the WWW for general users and for biologist programmers. Methods Mol. Biol. 132, 365-386 (2000)
22. A.G. Antonacopoulou, P.D. Grivas, L. Skarlas, M. Kalofonos, C. D. Scopa, H.P. Kalofonos, POLR2F, ATP6V0A1 and PRNP expression in colorectal cancer: New molecules with prognostic significance? Anticancer Res. 28, 1221-1227 (2008) (Pubitemid 351578860)
23. P.D. Grivas, A. Antonacopoulou, V. Tzelepi, G. Sotiropoulou-Bonikou, Z. Kefalopoulou, A.G. Papavassiliou, H. Kalofonos, HER-3 in colorectal tumourigenesis: From mRNA levels through protein status to clinicopathologic relationships. Eur. J. Cancer 43, 2602-2611 (2007) (Pubitemid 350103546)
24. K. Suga, T. Yamamoto, Y. Yamada, S. Miyatake, T. Nakagawa, N. Tanigawa, Correlation between transcriptional expression of survivin isoforms and clinicopathological findings in human colorectal carcinomas. Oncol. Rep. 13, 891-897 (2005)
25. F. Vegran, R. Boidot, C. Oudin, J.M. Riedinger, S. Lizard-Nacol, Distinct expression of Survivin splice variants in breast carcinomas. Int. J. Oncol. 27, 1151-1157 (2005)
26. S. Lankiewicz, E. Rother, S. Zimmermann, C.Hollmann, F.Korangy, T.F. Greten, Tumour-associated transcripts and EGFR deletion variants in colorectal cancer in primary tumour, metastases and circulating tumour cells. Cell. Oncol. 30, 463-471 (2008)
27. S. De Maria, G. Pannone, P. Bufo, A. Santoro, R. Serpico, S. Metafora, C. Rubini, D. Pasquali, S.M. Papagerakis, S. Staibano, G. De Rosa, E. Farina, M. Emanuelli, A. Santarelli, M.A. Mariggio, L. Lo Russo, L. Lo Muzio, Survivin gene-expression and splicing isoforms in oral squamous cell carcinoma. J. Cancer Res. Clin. Oncol. 135, 107-116 (2009)
28. T. Zhang, T. Otevrel, Z. Gao, Z. Gao, S.M. Ehrlich, J.Z. Fields, B. M. Boman, Evidence that APC regulates survivin expression: A possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res. 61, 8664-8667 (2001) (Pubitemid 34013874)
29. N. Zhu, L. Gu, H.W. Findley, F. Li, M. Zhou, An alternatively spliced survivin variant is positively regulated by p53 and sensitizes leukemia cells to chemotherapy. Oncogene 23, 7545-7551 (2004) (Pubitemid 39389696)
30. M. Gazouli, N. Tzanakis, G. Rallis, G. Theodoropoulos, I. Papaconstantinou, A. Kostakis, N.P. Anagnou, N. Nikiteas, Survivin -31 G/C promoter polymorphism and sporadic colorectal cancer. Int. J. Colorectal Dis. 24, 145-150 (2009)
31. J.G. Kalliakmanis, C. Kouvidou, C. Latoufis, G. Kouvatseas, D. Anagnostakis, G. Papatheodoridis, J. Koskinas, A. Archimandritis, Survivin expression in colorectal carcinomas: Correlations with clinicopathological parameters and survival. Dig. Dis. Sci. 55, 2958-2964 (2009)
32. P.N. Span, V.C. Tjan-Heijnen, J.J. Heuvel, J.B. de Kok, J.A. Foekens, F.C. Sweep, Do the survivin (BIRC5) splice variants modulate or add to the prognostic value of total survivin in breast cancer? Clin. Chem. 52, 1693-1700 (2006) (Pubitemid 44330703)
33. K. Komuro, M. Tada, E. Tamoto, A. Kawakami, A. Matsunaga, K. Teramoto, G. Shindoh, M. Takada, K. Murakawa, M. Kanai, N. Kobayashi, Y. Fujiwara, N. Nishimura, J. Hamada, A. Ishizu, H. Ikeda, S. Kondo, H. Katoh, T. Moriuchi, T. Yoshiki, Right-and left-sided colorectal cancers display distinct expression profiles and the anatomical stratification allows a high accuracy prediction of lymph node metastasis. J. Surg. Res. 124, 216-224 (2005) (Pubitemid 40463721)
34. R. Kannangai, J. Wang, Q.Z. Liu, F. Sahin, M. Torbenson, Survivin overexpression in hepatocellular carcinoma is associated with p53 dysregulation. Int. J. Gastrointest. Cancer 35, 53-60 (2005) (Pubitemid 40458580)
35. B. Ryan, N. O'Donovan, B. Browne, C. O'Shea, J. Crown, A.D. Hill, E. McDermott, N. O'Higgins, M.J. Duffy, Expression of survivin and its splice variants survivin-2B and survivin-DeltaEx3 in breast cancer. Br. J. Cancer 92, 120-124 (2005) (Pubitemid 40188444)
36. F. Li, J. Yang, N. Ramnath, M.M. Javle, D. Tan, Nuclear or cytoplasmic expression of survivin: What is the significance? Int. J. Cancer 114, 509-512 (2005) (Pubitemid 40349608)
37. W.S. Moon, A.S. Tarnawski, Nuclear translocation of survivin in hepatocellular carcinoma: A key to cancer cell growth? Hum. Pathol. 34, 1119-1126 (2003) (Pubitemid 37466997)
38. S. Peroukides, V. Bravou, A. Alexopoulos, J. Varakis, H. Kalofonos, H. Papadaki, Survivin overexpression in HCC and liver cirrhosis differentially correlates with p-STAT3 and E-cadherin. Histol. Histopathol. 25, 299-307 (2010)